Form 8-K - Current report:
SEC Accession No. 0001104659-25-054628
Filing Date
2025-05-30
Accepted
2025-05-30 10:07:23
Documents
15
Period of Report
2025-05-30
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2516558d1_8k.htm   iXBRL 8-K 53823
2 EXHIBIT 3.1 tm2516558d1_ex3-1.htm EX-3.1 78244
3 EXHIBIT 99.1 tm2516558d1_ex99-1.htm EX-99.1 133486
  Complete submission text file 0001104659-25-054628.txt   531830

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ckpt-20250530.xsd EX-101.SCH 3271
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ckpt-20250530_def.xml EX-101.DEF 26197
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ckpt-20250530_lab.xml EX-101.LAB 35951
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ckpt-20250530_pre.xml EX-101.PRE 24855
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2516558d1_8k_htm.xml XML 5067
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

EIN.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38128 | Film No.: 251007505
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)